BrightSpring Health Services, Inc. (BTSG) SEC Filings & Earnings Calls

Prescription volume flat YoY, indicating reliance on pricing for revenue growth.

“Prescriptions dispensed 10,844,038 vs 10,851,773 (0% change)”

Integration Risk from Acquisitions

“The Amedisys and LHC Branches Acquisition contributed $77.9 million and $156.4 million in revenue during the three and six months ended June 30, 2026, respectively. The allocation of the purchase price is provisional as of June 30, 2026.” · word for word

Tax Rate Volatility from Stock Compensation

“Excess tax benefits totaled $16.9 million and $29.3 million for the three and six months ended June 30, 2026, respectively, compared to $1.4 million and $3.7 million for the three and six months ended June 30, 2025. These benefits are recognized as discrete tax items in the periods in which awards vest or are exercised and can vary significantly based on the”

Secondary offering dilutes existing shareholders, though company repurchase partially offsets.

“14,999,771 shares sold by selling stockholders; company repurchased 1,026,465 shares.”

Divestiture of Community Living business closed; gain on sale of $31.2M recorded in discontinued operations.

“Divestiture of Community Living business to Sevita closed on March 30, 2026, which resulted in a $31.2 million gain on sale” · word for word

Dependence on Government Payors

“The Company is substantially dependent on revenues received under contracts with federal, state, and local government agencies.” · word for word

Integration Risk from Acquisitions

“The Amedisys and LHC Branches Acquisition contributed $78.5 million in revenue and $7.4 million in operating income during the three months ended March 31, 2026.” · word for word

Interest Rate Exposure

“The Company has $2,514,872 in variable-rate debt at SOFR plus 2.50%, with interest rate swaps hedging $1,500 million notional.”

KKR Stockholder Ownership Reduction

“KKR Stockholder ownership reduced to 21.7% from majority, company no longer qualifies as controlled company.”

Key Person Dependence on CEO

“CEO compensation is heavily weighted on performance, with significant equity awards and severance benefits.”

Divestiture reduces revenue base but improves focus and leverage; execution risk in transition.

“Divestiture of Community Living business to Sevita closed on March 30, 2026”

Dilution from secondary offering; selling stockholders reducing stake may signal lack of confidence.

“20M shares sold by KKR and management selling stockholders.”

Divestiture of Community Living business reduces scale; integration of acquired branches may pose challenges.

“Planned divestiture of Community Living business to Sevita expected to close Q1 2026.” · word for word

Gross margin compression from specialty drug mix shift

“Gross profit margin for the year ended December 31, 2025 was 8.2% compared to 8.5% for the year ended December 31, 2024. The decrease in gross profit margin is due to mix shift in the Pharmacy Solutions segment with greater relative volume growth in Infusion and Specialty Pharmacy.” · word for word

Regulatory and compliance risk in healthcare

“Risk factors describe extensive regulation under HIPAA, FDA, state laws, and potential audits, but no specific current impact quantified.”

Planned divestiture of Community Living business may cause operational disruption.

“Planned divestiture of Community Living business to Sevita, expected to close in Q1 2026.” · word for word

Leverage at 3.31x could limit financial flexibility.

“Leverage was 3.31x, as calculated under our First Lien Credit Agreement at September 30, 2025.” · word for word

Legal Settlement Exposure

“The total financial impact of the settlement was $120.0 million; $90.0 million was paid in June 2024, $20.0 million was paid in July 2024, and the remaining $10.0 million was paid in April 2025.” · word for word